Prolife Industries Ltd.

As of March 31, 2025, Prolife Industries Ltd. carries a market capitalization of 901.31M, placing it among publicly traded companies globally. Its enterprise value stands at 752.73M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2025, Prolife Industries Ltd. has 4.09M shares outstanding.

These figures are as of March 31, 2025.

As of March 31, 2025, Prolife Industries Ltd. maintains a current ratio of 6.99, meaning it holds 7.0x the short-term assets needed to cover near-term liabilities.

As of the close on October 6, 2026, Prolife Industries Ltd.'s stock has declined approximately 30.00% over the past 52 weeks. The 50-day moving average sits at 73.63, while the 200-day moving average is 93.04.

As of March 31, 2025, Prolife Industries Ltd. holds 174.42M in cash and equivalents against 25.83M in total debt, resulting in a net debt position of -148.58M. Total book value stands at 454.72M, with working capital of 280.61M providing operational flexibility.